Literature DB >> 14766888

Immunologically silent autochthonous acute hepatitis E virus infection in France.

Jean Michel Mansuy1, Jean Marie Peron, Christophe Bureau, Laurent Alric, Jean Pierre Vinel, Jacques Izopet.   

Abstract

Hepatitis E is an acute and self-limiting hepatitis, and the causative agent, hepatitis E virus, is excreted in feces and orally transmitted. The disease is common in Asia and Africa, causing outbreaks or sporadic cases. In Europe, the infection is generally observed after a history of travel in an area of endemicity. We report on an autochthonous case in southwestern France in which the diagnosis was based on molecular tools rather than serological testing.

Entities:  

Mesh：

Year:  2004        PMID： 14766888      PMCID： PMC344494          DOI： 10.1128/JCM.42.2.912-913.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Viraemia and faecal shedding of HEV in symptom-free carriers.

Authors:  E Nicand; M Grandadam; R Teyssou; J L Rey; Y Buisson
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

2.  HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain.

Authors:  S Pina; M Buti; M Cotrina; J Piella; R Girones
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

3.  High prevalence of hepatitis E antibodies among Danish prisoners and drug users.

Authors:  Peer B Christensen; Ronald E Engle; Svend Erik H Jacobsen; Henrik B Krarup; Jørgen Georgsen; Robert H Purcell
Journal:  J Med Virol       Date:  2002-01       Impact factor: 2.327

4.  Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States.

Authors:  G Haqshenas; H L Shivaprasad; P R Woolcock; D H Read; X J Meng
Journal:  J Gen Virol       Date:  2001-10       Impact factor: 3.891

5.  Sporadic acute hepatitis E of a 47-year-old man whose pet cat was positive for antibody to hepatitis E virus.

Authors:  Akiko Kuno; Kenichi Ido; Norio Isoda; Yoshiaki Satoh; Kazunori Ono; Shin Satoh; Hideaki Inamori; Kentaro Sugano; Nobuyuki Kanai; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Hepatol Res       Date:  2003-07       Impact factor: 4.288

6.  Zoonotic transmission of hepatitis E virus from deer to human beings.

Authors:  Shuchin Tei; Naoto Kitajima; Kazuaki Takahashi; Shunji Mishiro
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

7.  Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands.

Authors:  W H van der Poel; F Verschoor; R van der Heide; M I Herrera; A Vivo; M Kooreman; A M de Roda Husman
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883
  7 in total
  5 in total

Review 1.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 2.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

3.  Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.

Authors:  M Herremans; J Bakker; E Duizer; H Vennema; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

4.  Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.

Authors:  Tanja Vollmer; Juergen Diekmann; Matthias Eberhardt; Cornelius Knabbe; Jens Dreier
Journal:  Viruses       Date:  2016-08-22       Impact factor: 5.048

5.  Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.

Authors:  Tanja Vollmer; Juergen Diekmann; Matthias Eberhardt; Cornelius Knabbe; Jens Dreier
Journal:  Euro Surveill       Date:  2016-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.